For the purpose of improving the lysosomal targeting and anti-tumor effect of CUR, Wang et al. [211] prepared Gal- and morpholine (Mor)-modified dual-targeting CUR liposomes (Gal-Mor-LPs). This evidence concerns the gene GAL and neoplasm.